BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 8258337)

  • 1. A Simple and Rapid Method for Quality Control of Major Histocompatibility Complex-Peptide Monomers by Flow Cytometry.
    Chandran PA; Heidu S; Zelba H; Schmid-Horch B; Rammensee HG; Pascolo S; Gouttefangeas C
    Front Immunol; 2017; 8():96. PubMed ID: 28228758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syncytia formation by SARS-CoV-2-infected cells.
    Buchrieser J; Dufloo J; Hubert M; Monel B; Planas D; Rajah MM; Planchais C; Porrot F; Guivel-Benhassine F; Van der Werf S; Casartelli N; Mouquet H; Bruel T; Schwartz O
    EMBO J; 2020 Dec; 39(23):e106267. PubMed ID: 33051876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells.
    Montealegre S; van Endert PM
    Front Immunol; 2018; 9():3098. PubMed ID: 30666258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation.
    Le Gall S; Buseyne F; Trocha A; Walker BD; Heard JM; Schwartz O
    J Virol; 2000 Oct; 74(19):9256-66. PubMed ID: 10982373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.
    Greenberg ME; Iafrate AJ; Skowronski J
    EMBO J; 1998 May; 17(10):2777-89. PubMed ID: 9582271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
    Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
    Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structure of MHC molecules and binding peptides].
    Takiguchi M
    Nihon Rinsho; 1994 Nov; 52(11):2817-23. PubMed ID: 7996674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC molecules as peptide receptors.
    Rammensee HG; Falk K; Rötzschke O
    Curr Opin Immunol; 1993 Feb; 5(1):35-44. PubMed ID: 7680871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells.
    Abdel-Motal UM; Berg L; Rosén A; Bengtsson M; Thorpe CJ; Kihlberg J; Dahmén J; Magnusson G; Karlsson KA; Jondal M
    Eur J Immunol; 1996 Mar; 26(3):544-51. PubMed ID: 8605919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylphosphatidylinositol-linked Db does not induce an influenza-specific cytotoxic T lymphocyte response or recycle membrane-bound peptides.
    Abdel Motal UM; Sentman CL; Zhou X; Robinson PJ; Dahmén J; Jondal M
    Eur J Immunol; 1995 Apr; 25(4):1121-4. PubMed ID: 7737284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells.
    Bellone M; Iezzi G; Manfredi AA; Protti MP; Dellabona P; Casorati G; Rugarli C
    Eur J Immunol; 1994 Nov; 24(11):2691-8. PubMed ID: 7525300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex class I-binding peptides are recycled to the cell surface after internalization.
    Abdel Motal UM; Zhou X; Joki A; Siddiqi AR; Srinivasa BR; Stenvall K; Dahmén J; Jondal M
    Eur J Immunol; 1993 Dec; 23(12):3224-9. PubMed ID: 8258337
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.